Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Taxol | 0.01 | uM | 4 | 2500.00 | 1726.92 | 1218.00 | 3321.50 | 0.3667 | -0.3093 |
| SK-BR-3 | Palbociclib | 0.1 | uM | 4 | 2500.00 | 1726.92 | 2517.00 | 3321.50 | 0.7578 | 0.4907 |
| SK-BR-3 | Methotrexate | 1 | uM | 4 | 2500.00 | 1726.92 | 1888.00 | 3321.50 | 0.5684 | 0.0991 |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3343.00 | 3321.50 | 1.0065 | 1.0137 | |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3470.00 | 3321.50 | 1.0447 | 1.0949 | |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3458.00 | 3321.50 | 1.0411 | 1.0872 | |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 2732.00 | 3321.50 | 0.8225 | 0.6260 | |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3312.00 | 3321.50 | 0.9971 | 0.9939 | |
| SK-BR-3 | Taxol | 0.00033113 | uM | 4 | 2500.00 | 1726.92 | 3174.00 | 3321.50 | 0.9556 | 0.9060 |
| SK-BR-3 | Methotrexate | 0.01 | uM | 4 | 2500.00 | 1726.92 | 3038.00 | 3321.50 | 0.9147 | 0.8196 |
| SK-BR-3 | Omipalisib | 1 | uM | 4 | 2500.00 | 1726.92 | 1097.00 | 3321.50 | 0.3303 | -0.3818 |
| SK-BR-3 | Methotrexate | 10 | uM | 4 | 2500.00 | 1726.92 | 1946.00 | 3321.50 | 0.5859 | 0.1349 |
| SK-BR-3 | Palbociclib | 1 | uM | 4 | 2500.00 | 1726.92 | 2264.00 | 3321.50 | 0.6816 | 0.3324 |
| SK-BR-3 | Methotrexate | 0.31623 | uM | 4 | 2500.00 | 1726.92 | 2350.00 | 3321.50 | 0.7075 | 0.3861 |
| SK-BR-3 | Taxol | 0.0031623 | uM | 4 | 2500.00 | 1726.92 | 2273.00 | 3321.50 | 0.6843 | 0.3380 |
| SK-BR-3 | Methotrexate | 0.1 | uM | 4 | 2500.00 | 1726.92 | 2094.00 | 3321.50 | 0.6304 | 0.2266 |
| SK-BR-3 | Omipalisib | 0.31623 | uM | 4 | 2500.00 | 1726.92 | 1446.00 | 3321.50 | 0.4354 | -0.1715 |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3353.00 | 3321.50 | 1.0095 | 1.0201 | |
| SK-BR-3 | Palbociclib | 0.31623 | uM | 4 | 2500.00 | 1726.92 | 2340.00 | 3321.50 | 0.7045 | 0.3798 |
| SK-BR-3 | Omipalisib | 0.01 | uM | 4 | 2500.00 | 1726.92 | 1844.00 | 3321.50 | 0.5552 | 0.0720 |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3278.00 | 3321.50 | 0.9869 | 0.9723 | |
| SK-BR-3 | Omipalisib | 0.0033113 | uM | 4 | 2500.00 | 1726.92 | 2004.00 | 3321.50 | 0.6033 | 0.1708 |
| SK-BR-3 | Taxol | 0.1 | uM | 4 | 2500.00 | 1726.92 | 1194.00 | 3321.50 | 0.3595 | -0.3237 |
| SK-BR-3 | Taxol | 0.001 | uM | 4 | 2500.00 | 1726.92 | 3208.00 | 3321.50 | 0.9658 | 0.9277 |
| SK-BR-3 | Palbociclib | 3.1623 | uM | 4 | 2500.00 | 1726.92 | 2063.00 | 3321.50 | 0.6211 | 0.2074 |